Spotlight: Caitlin Murdoch, Ph.D.

Caitlin Murdoch Ph.D. is a postdoctoral fellow in the Eric Skaar lab in the department of Pathology, Microbiology and Immunology. Caitlin grew up on Merritt Island, a barrier island on Florida’s Space Coast. After receiving her B.S. in Microbiology from the University of Florida, she moved to Durham, NC to pursue graduate studies at Duke University. There, she earned her PhD in Molecular Genetics and Microbiology in the lab of Dr. John Rawls. For her dissertation, she used zebrafish to study mechanisms by which the microbiota shape the development of the innate immune system. In the Skaar lab, Caitlin continues to use gnotobiotic zebrafish as a model to investigate the impact of metals on shaping inter-bacterial interactions in the intestine.....Click the image on the left to continue reading.

The evolution of mRNA vaccines alongside SARS-COV-2

SARS-CoV-2 has mutated and evolved to partially evade the immune response generated from prior vaccination or infection. The development of mRNA technology allows for rapid reprogramming of the coding sequence to modify the immune response mounted by the vaccine. Although the long-term trajectory for vaccination recommendations remain unclear, the advanced mRNA vaccine technology allows for the combination and modulation of the targeted sequence to modify the potency of the immune response.... continue reading.

SARS-CoV-2 evolution and implications for immunity

While COVID-19 is no longer plaguing media outlets, the virus remains a serious threat to human health. Since the discovery of SARS-CoV-2, the virus and its transmissibility evolved. The Omicron variant is the dominant circulating virus that causes COVID-19 in the United States and is capable of evading pre-existing immunity, causing serious public health concern. In fact, the greatest number of COVID-19 related hospitalizations occurred during the first Omicron wave. With high burdens of respiratory syncytial virus (RSV) and influenza this season, it is important to remain vigilant and take steps to prevent severe COVID-19 illness.....continue reading.

Spotlight: Jane Ferguson, Ph.D.

Jane Ferguson Ph.D. is an Associate Professor of Medicine in the Division of Cardiovascular Medicine and an Associate Director of the Vanderbilt Microbiome Innovation Center. Dr. Ferguson completed a BA in Human Genetics at Trinity College Dublin, and a PhD in Nutrigenomics at University College Dublin, Ireland, before moving to Philadelphia for postdoctoral training in Cardiovascular Genomics at the University of Pennsylvania. Dr. Ferguson moved to Nashville to join the faculty at Vanderbilt in October 2014.....Click the image on the left to continue reading.